Development of doxorubicin loading platform based albumin-sporopollenin as drug carrier.

Biochem Biophys Rep

Department of Chemistry, Selcuk University, 42075 Konya, Turkey.

Published: September 2016

Albumin is thought as an drug carrier for doxorubicin (DOX). The binding of doxorubicin to albumin was studied on the surface of sporopolleninin (SP) to produce a new drug system based natural materials. Human serum albumin (HSA) was immobilized on SPIONs in 20 mM Tris buffer, 7.4 of pH. Data showed that binding amount of HSA has been found to be as 285.53 µg to the 25 mg of Sporopolleninin which also bounded 319.76 µM of DOX. Binding of protein and drug to Sp were clarified by SEM, EDX and FT-IR analysis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613350PMC
http://dx.doi.org/10.1016/j.bbrep.2016.06.012DOI Listing

Publication Analysis

Top Keywords

drug carrier
8
dox binding
8
development doxorubicin
4
doxorubicin loading
4
loading platform
4
platform based
4
based albumin-sporopollenin
4
drug
4
albumin-sporopollenin drug
4
carrier albumin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!